Not yet recruitingNCT06011226
Development of a Patient-reported Outcome Measure for Chiari Malformation and Syringomyelia
Studying OBSOLETE: Primary syringomyelia/hydromyelia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Steven KNAFOAssistance Publique - Hôpitaux de Paris, Hôpital Bicêtre
- Intervention
- focus groups(other)
- Enrollment
- 60 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- Hôpital Bicêtre - Service de Neurochirurgie - CRMR C-MAVEM, Le Kremlin-Bicêtre, France
Collaborators
Institut National de la Santé Et de la Recherche Médicale, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06011226 on ClinicalTrials.govOther trials for OBSOLETE: Primary syringomyelia/hydromyelia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07295067Extracellular Vesicles for the Treatment of SyringomyeliaXuanwu Hospital, Beijing
- ACTIVE NOT RECRUITINGNCT01150708A Prospective Natural History Study of Patients With SyringomyeliaNational Institute of Neurological Disorders and Stroke (NINDS)
See all trials for OBSOLETE: Primary syringomyelia/hydromyelia →